bioRxiv·8 OctOral administration of dibenzoylmethane (DBM) prevents cognitive decline in a C9ORF72-mediated FTD mouse modelPreprint: experiments in animalsInterventionsPaper
Brain·5 SepProgress towards a biotypic biomarker profile for amyotrophic lateral sclerosis-frontotemporal spectrum disordersReviewBiomarkersPaper
bioRxiv·31 AugCerebrospinal fluid YWHAG:NPTX2 ratio predicts clinical severity and future phenoconversion in frontotemporal lobar degenerationPreprint: cohort study in peopleBiomarkersPaper
bioRxiv·20 AugProgranulin deficiency perturbs lipid metabolism in white matter microgliaPreprint: experiments in miceLipid and ceramide metabolismPaper
Alzheimer's Research & Therapy·14 AugThe UNC13A cryptic exon associates with cognitive impairment in Alzheimer's diseaseStudy in peopleMechanismsPaper
AAIC 2025 Abstract·26 DecClinical associations of CSF TMEM106B in familial and sporadic frontotemporal lobar degenerationStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecTargeted proteomics via NULISAseq identifies blood‐detectable markers of disease progression in familial frontotemporal lobar degenerationStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecFine‐mapping of the TMEM106B locus reveals four haplotypes that are differentially associated with risk for neurodegenerationStudy in peopleMechanismsPaper